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Background. Symptoms of idiopathic overactive bladder (iOAB) affect ∼17 % worldwide of 
women, and its prevalence increases with patient age. Autonomic dysfunction in the genital 
area can be assessed using sympathetic skin response (SSR). SSR tests can be used for the 
detection of early iOAB and assessing those likely to be refractory to anticholinergic drugs. 
Treatments options for iOAB include lifestyle modifications, behavioural therapy, 
pharmacotherapy, neuromodulation, Botulinum toxin therapy and surgical interventions. The 
American Urological Association and the European Association of Urology recommend 
bladder wall injection with Botulinum neurotoxin A (BoNT-A) in women with idiopathic 
detrusor overactivity who have not responded to conservative treatment.  
Case report. Pacient I., female, age 31 years, diagnosed clinical with iOAB, confirmed on 
urodynamics, underwent the SSR investigation for assessment of autonomic nervous system. 
The patient had been refractory to different anticholinergic drugs and there was no response to 
conservative therapy for over 10 years. Before injection, patient was asked to complete a 4-day 
voiding diary, to record the quantification, the frequency of voids, the number of incontinence 
episodes and the number of episodes of nocturia. The treatment started with antibiotic 
prophylaxis (ciprofloxacin 1g i/v twice daily) for 1 day before the injection procedure and 
continued for 3 days after treatment. Saline cystoscopy was performed using a 19-F rigid 
cystoscope, under i/v anaesthesia. BoNT-A (100 UI) was mixed with 10 ml 0.9 % sodium 
chloride and administered 1 ml over 20 different sites, each 1 cm apart, supratrigonally, using 
18-gauge needle for rigid cystoscopies, inserted 3 mm into the bladder wall. After 2-3h of 
procedure was a successful demonstration of voiding. The woman didn’t develop any adverse 
effects like urinary tract infection, gross haematuria, injection site pain or urinary retention. 
Follow-up at 1, 3, 6, 9 and 12 months, with 4-day voiding diaries, clinical and SSR was carried 
out. Injections increased voided volume >90 ml, decreased urinary frequency, absence of 
nocturia and improved QoL. Clinical effects of BoNT-A were evident in 1 week and last up to 
12 months. The results of SSR before and after a week of injection estableshed the significantly 
pronounced changes in time taken for the ascending wave A1 (parasympathetic component) 
compering with time taken for the ascending wave A2 (sympathetic component). Before 
injection of BoNT-A mean score was S1A1=0,5sec., S2aA2=0,94 sec., after injection 
respectively was 0,34 sec. and 1,1 sec.  
Conclusions. Botulinum toxin type A might be an alternative to invasive surgery for patients 
in whom conservative measures for treatment of iOAB have failed. The SSR can serve as a 
complex diagnostic of iOAB and assessment the efficiency of treatment with BoNT-A.   
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Background. Ocular burns represent about 11-22% of ocular trauma. The most affected are 
young men, 20-40 y. o. These can happen anywhere, at home, work or after physical 
aggression. The most severe damage is due to acids and alkali. They can destroy limbal stem 
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cells and produce recurrent epithelial ulcerations, chronic stromal ulcers, deep stromal 
vascularization and corneal perforation, in this way leading to blindness. Acid ocular burns are 
produced by: sulfuric acid (battery acid, industrial cleaner), acetic acid (vinegar), hydrochloric 
acid (chemical laboratories), sulfurous acid (bleach, refrigerant, fruit and vegetable 
preservative). Alkali burns: ammonia (fertilizers, refrigerants), lye (drain cleaner), lime 
(plastic, mortar, cement, whitewash), potassium hydroxide (caustic potash), magnesium 
hydroxide (sparklers, incendiary devices). In our case, patient’s burn was due to salicylic acid 
(a component used for preparing drops to treat dermatomycosis).  
Case report. A 42 y.o. male presented to our clinic with right eye pain, redness and decrease 
of visual acuity for two weeks, when he accidentally instilled a drop of topical dermatomycosis 
medication (wich contains salicylic acid of 10%, ethanol 3%, phenol 1% and preservatives) 
considering it as artificial tears. That led to severe ocular pain, irritation, watering and 
photophobia. Clinical examination revealed: VA OD/OS = 0,01/0,67; at slit lamp 
biomicroscopy - diffuse conjunctival congestion with corneal epithelial defect of 6 × 5.7 mm 
involving the central visual axis with swollen rounded edges and surrounding area of corneal 
edema. After saline wash, the patient started on topical moxifloxacin 0.5%, dexamethasone 
0.1%, vitamin C drops, hydroxy propyl methyl cellulose 0.3%, and carboxymethylcellulose gel 
1% along with oral doxycycline 100 mg and vitamin C 500 mg., subconjunctival autologous 
serum and 2 amniotic membrane transplantation were performed. The defect healed leaving 
behind a macular corneal opacity after a period of 10 weeks, VA OD= 0,16.  
Conclusions. 1. Salicylic acid and phenol are frequently used for most dermatological drugs. 
They affect the ocular surface, causing chemical burns. 2. The release of dermatological drugs 
similar to ophthalmic solutions in vials is a risk factor for confusing them, especially if the 
patient has visual impairment, is mentally deficient, or simply is in a hurry. 3. The treatment 
of chemical burns is very challenging and often ends with blindness.  
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Background. Nowadays, glaucoma imposes a major issue for public health, representing the 
second worldwide leading cause of blindness (WHO Resnikoff 2002). It is a group of complex 
and heterogeneous ocular diseases, characterized by progressive optical atrophy (Almasieh 
2012; Yanoff, 2014; Salmon, 2020). Glaucomatous damage is irreversible; therefore 
understanding its pathology and selection of optimal management minimizes the risk of 
progression and development of visual loss. That is why the researches continue. We report a 
case of filtration surgery treatment in experimentally induced ocular hypertension.  
Case report. Since for reliable tonometry in awake rabbits, it is advisable to keep the animals 
as quiet and unfrightened as possible, avoiding excessive manipulation and stimulation, we 
thought of using Tono-PenXL© Reichert at New Zealand rabbit and to take the measurement 
of normal IOP (intraocular pressure) after surface anesthesia. An ocular hypertension model in 
